Precision oncology: separating the wheat from the chaff
- PMID: 30425845
- PMCID: PMC6212683
- DOI: 10.1136/esmoopen-2018-000446
Precision oncology: separating the wheat from the chaff
Abstract
Precision oncology based on next-generation sequencing (NGS) test is growing in daily clinical practice. However, the real impact of this strategy in patients' outcome on a large scale remains uncertain. In this review, we summarise existing literature on this topic, limitations for broad NGS implementation, bottlenecks in genomic variant interpretation and the role of molecular tumour boards.
Keywords: next-generation sequencing; oncogenic-addicted tumors; personalized medicine.
Conflict of interest statement
Competing interests: None declared.
References
-
- Cancer Research UK Worldwide cancer statistics. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/wo...
LinkOut - more resources
Full Text Sources